What does V.V.Ryckmans - Medical do?

V.V.Ryckmans - Medical is a specialist medical practice in Oudergem. Private Limited, started on 26 December 2007, 2 establishments.

What is the address of V.V.Ryckmans - Medical?

The registered office of V.V.Ryckmans - Medical is located at Paul Verheyleweghenlaan 1, 1160 Oudergem.

Is V.V.Ryckmans - Medical still active?

Yes. According to the CBE (2 November 2026) V.V.Ryckmans - Medical is active, legal situation “Normale toestand”, started on 26 December 2007.

Is V.V.Ryckmans - Medical registered on Peppol?

No, V.V.Ryckmans - Medical is currently not registered on the Peppol network.

What is the enterprise number of V.V.Ryckmans - Medical?

The enterprise number of V.V.Ryckmans - Medical is BE0894473226.

When was V.V.Ryckmans - Medical founded?

V.V.Ryckmans - Medical was founded on 26 December 2007.

Who are the directors of V.V.Ryckmans - Medical?

According to the 2025 annual accounts, the directors of V.V.Ryckmans - Medical are: Vincent Ryckmans.

Is V.V.Ryckmans - Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE; 1 events from the Belgian Official Gazette processed.

How much profit did V.V.Ryckmans - Medical make in 2025?

V.V.Ryckmans - Medical posted a profit after taxes of € 2,693 in financial year 2025.

What is the revenue of V.V.Ryckmans - Medical?

As a small company, V.V.Ryckmans - Medical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 70,647.

V.V.Ryckmans - Medical (Private Limited) - Oudergem

Dossier V.V.Ryckmans - Medical, printed on 3 November 2026 from databakkes.be/en/0894473226/v-v-ryckmans-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 62 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

V.V.Ryckmans - Medical from Oudergem, company number BE0894473226, closed financial year 2025 with a result of € 2,693 after tax. For that financial year V.V.Ryckmans - Medical recorded a gross margin of € 70,647 and equity of € -28,704. Compared with financial year 2024, the result moved from € 1,359 to € 2,693. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 27, 2026.

What it is worth Caution

€ -28,704

▲ € 2,693 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 2,693

▲ 98% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,485

▲ € 9,286 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -47,477.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 26,052

▲ € 22,388 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 154,405

▼ 26% vs 2024

€ 51,953 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 56,597

▲ € 46,520 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,664

▲ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 77,434 Gross margin 2022: € 77,434 First fiscal year in the series	€ 69,776 Gross margin 2023: € 69,776 ▼ 10% vs 2022 (€ 77,434) Unfavourable step	€ 68,501 Gross margin 2024: € 68,501 ▼ 2% vs 2023 (€ 69,776) Unfavourable step	€ 70,647 Gross margin 2025: € 70,647 ▲ 3% vs 2024 (€ 68,501) Favourable step	▲ 3%
Profit after taxes	€ 2,590 Profit after taxes 2022: € 2,590 First fiscal year in the series	€ 245 Profit after taxes 2023: € 245 ▼ 91% vs 2022 (€ 2,590) Unfavourable step	€ 1,359 Profit after taxes 2024: € 1,359 ▲ € 1,113 vs 2023 (€ 245) Favourable step	€ 2,693 Profit after taxes 2025: € 2,693 ▲ 98% vs 2024 (€ 1,359) Favourable step	▲ 98%
Equity	€ -33,001 Equity 2022: € -33,001 First fiscal year in the series	€ -32,756 Equity 2023: € -32,756 ▲ € 245 vs 2022 (€ -33,001) Favourable step	€ -31,397 Equity 2024: € -31,397 ▲ € 1,359 vs 2023 (€ -32,756) Favourable step	€ -28,704 Equity 2025: € -28,704 ▲ € 2,693 vs 2024 (€ -31,397) Favourable step	▲ € 2,693
Total debts	€ 399,388 Total debts 2022: € 399,388 First fiscal year in the series	€ 346,933 Total debts 2023: € 346,933 ▼ 13% vs 2022 (€ 399,388) Favourable step	€ 332,251 Total debts 2024: € 332,251 ▼ 4% vs 2023 (€ 346,933) Favourable step	€ 294,777 Total debts 2025: € 294,777 ▼ 11% vs 2024 (€ 332,251) Favourable step	▼ 11%
Cash	€ 2,993 Cash 2022: € 2,993 First fiscal year in the series	€ 3,990 Cash 2023: € 3,990 ▲ 33% vs 2022 (€ 2,993) Favourable step	€ 199 Cash 2024: € 199 ▼ 95% vs 2023 (€ 3,990) Unfavourable step	€ 9,485 Cash 2025: € 9,485 ▲ € 9,286 vs 2024 (€ 199) Favourable step	▲ € 9,286
Land & buildings	€ 198,183 Land & buildings 2022: € 198,183 First fiscal year in the series	€ 161,595 Land & buildings 2023: € 161,595 ▼ 18% vs 2022 (€ 198,183) Unchanged	€ 125,008 Land & buildings 2024: € 125,008 ▼ 23% vs 2023 (€ 161,595) Unchanged	€ 88,420 Land & buildings 2025: € 88,420 ▼ 29% vs 2024 (€ 125,008) Unchanged	▼ 29%
Retained profit	€ -51,774 Retained profit 2022: € -51,774 First fiscal year in the series	€ -51,529 Retained profit 2023: € -51,529 Unchanged (€ -51,774) Favourable step	€ -50,170 Retained profit 2024: € -50,170 ▲ € 1,359 vs 2023 (€ -51,529) Favourable step	€ -47,477 Retained profit 2025: € -47,477 ▲ € 2,693 vs 2024 (€ -50,170) Favourable step	▲ € 2,693
Bank debt	€ 319,166 Bank debt 2022: € 319,166 First fiscal year in the series	€ 241,115 Bank debt 2023: € 241,115 ▼ 24% vs 2022 (€ 319,166) Favourable step	€ 209,939 Bank debt 2024: € 209,939 ▼ 13% vs 2023 (€ 241,115) Favourable step	€ 154,405 Bank debt 2025: € 154,405 ▼ 26% vs 2024 (€ 209,939) Favourable step	▼ 26%
Balance sheet total	€ 366,387 Balance sheet total 2022: € 366,387 First fiscal year in the series	€ 314,177 Balance sheet total 2023: € 314,177 ▼ 14% vs 2022 (€ 366,387) Unchanged	€ 300,854 Balance sheet total 2024: € 300,854 ▼ 4% vs 2023 (€ 314,177) Unchanged	€ 266,073 Balance sheet total 2025: € 266,073 ▼ 12% vs 2024 (€ 300,854) Unchanged	▼ 12%

Key figures of V.V.Ryckmans - Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 3 March 2027.

What happened to V.V.Ryckmans - Medical?

What happened at V.V.Ryckmans - Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 27, 2026 New annual accounts for financial year 2025: profit of € 2,693 (▲ 98% vs 2024). Source: NBB ↗
Jan 1, 2025 New establishment in Oudergem. KBO
Dec 28, 2007 Incorporation, published in the Gazette. Source: Staatsblad ↗
Dec 26, 2007 New establishment in Lasne. KBO

In short

From € 2,590 profit in 2022 to € 2,693 profit in 2025.

Paid € 17,395 in corporate taxes since 2022.

Best year ever: 2025, with € 2,693 profit.

Original PDFs at the National Bank ↗

Management

Vincent Ryckmans

V.V.Ryckmans - Medical

TERRA INCOGNITA PROJECTS

Behind V.V.Ryckmans - Medical is Vincent Ryckmans. Vincent Ryckmans is also behind TERRA INCOGNITA PROJECTS.

Directors

According to the 2025 annual accounts

Vincent Ryckmans

Manager

Also active at: TERRA INCOGNITA PROJECTS

Establishments

Establishment units

Physical locations of this company

Registered office

Paul Verheyleweghenlaan 1

1160 Oudergem

2.302.036.464

Rue d'Alaumont 11

1380 Lasne

Active since 26 December 2007

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Association des copropriétaires de la Résidence sise à Auderghem, avenue Paul Verheyleweghen 1

TERRA INCOGNITA PROJECTS same network

€ 58,909 gross margin · 2025

SOS PHARMACIEN

€ 92,699 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

28 December 2007 Source: Deed ↗

RYCKMANS Vincent-Paul-Patrick(oprichter) 100%

Details

Company number: 0894.473.226
VAT number: BE 0894.473.226
Registered office: Paul Verheyleweghenlaan 1, 1160 Oudergem
Names & denominations: V.V.Ryckmans - Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 December 2007
Peppol: Not registered
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗